RecruitingNot ApplicableNCT05678023

Study About Contrast Media

Multicentre Randomized Trial on the Timing and Effect of Contrast Media on Patients with Adhesive Small Bowel Obstruction

Sponsor

University of Tartu

Enrollment

120 participants

Start Date

Sep 1, 2023

Study Type

INTERVENTIONAL

Summary

Patients hospitalized with adhesive small bowel obstruction (SBO) are randomized to 2 study groups at admission after signing an informed consent form. Water-soluble contrast media (CM) will be administered after 4 or after 24 hours of nasogastric- tube decompression.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Patients 18 years or older
Adhesive small bowel obstruction diagnosed (clinical, laboratory and radiologic evaluation
No peritonitis present, no need for an emergent surgery
Patients sign an informed consent

Exclusion Criteria6

Patients younger than 18 yeas
Patients with mechanical small bowel obstruction caused by incarcerated hernias
Patients with mechanical small bowel obstruction caused by carcinomatosis
Patients with paralytic small bowel obstruction
Patients who have undergone surgery within 6 weeks
Patients who do not want to be enrolled in the study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHEREffect on contrast media depending on the time of its administratsion

CM is a common practice when it comes to the management of small bowel obstruction. However there is no consensus as when it should be administered

Locations(1)

Tartu University Hospital

Tartu, Tartu, Estonia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05678023